Delivery Order SPE2DB20D2014-SPE2DB23FD12R
Award Date 8/18/23
Potential Completion Date 8/21/23
Potential Value $30K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,927 delivery order to Amerisourcebergen Drug Corporation for the provision of HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. The firm fixed price order is being carried out under an existing DLA contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period concluding on August 28, 2023. No subcontractors or set...
- The Defense Logistics Agency awarded a $11,744.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. The delivery order was issued against an existing DLA pharmaceutical supply contract vehicle. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required between September 15-18, 2023. No subcontractors or set aside designations were identified. The DLA manages the global...
- The Defense Logistics Agency awarded a $9,223.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. The delivery order was issued against an existing DLA pharmaceutical supply contract vehicle. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from September 20th through September 21st, 2023. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency awarded a $20,583.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. The delivery order was issued against an existing DLA contract vehicle to provide the pharmaceutical product for use by Department of Defense personnel. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from August 11-14, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $32,371 delivery order to Amerisourcebergen Drug Corporation for HUMIRA(CF) PEN 80 MG/0.8 MLS syringes. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support Defense Logistics Agency requirements. No additional context was provided regarding the Defense Logistics Agency's programs or whether this delivery order is associated with any particular contract vehicles. The order period of performance...
- <p>The Defense Logistics Agency awarded a $26,703 delivery order to Amerisourcebergen Drug Corporation for HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the larger vehicle or any subcontractors involved. The order has a period of performance from July 14, 2023 through July 17, 2023.</p>
- The Defense Logistics Agency awarded a $56,473 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. The single award was issued under an existing Prime Vendor contract vehicle to support the Department of Defense's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 31, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $11,744.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a period of performance from June 29, 2023 through June 30, 2023 with all work to be completed at Amerisourcebergen's facility located in Conshohocken, Pennsylvania. As the DLA is responsible for procuring pharmaceuticals and medical supplies for the Department of Defense, this delivery order was likely placed...
- The Defense Logistics Agency awarded a $17,884.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements. The delivery order was issued under an existing DLA-wide supply contract vehicle and has a period of performance spanning September 8 through 11,...
- The Defense Logistics Agency awarded a $17,077.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. The contract has a period of performance from September 25, 2023 through September 26, 2023, with all work to be performed by Amerisourcebergen at its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency routinely utilizes indefinite delivery/indefinite quantity contracts to procure...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FD12RDelivery Order
The Defense Logistics Agency awarded a $29,723 delivery order to Amerisourcebergen Drug Corporation for HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were identified. The delivery order was issued under an existing DLA pharmaceutical supply contract vehicle and will provide the specified medication to DLA from August 18-21, 2023 to support the agency's mission of providing critical resources to the U.S. Department of Defense.
Generated 12/23/23, 12:46 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.7k | 8/18/23 |